We leverage partners and networks to address disease surveillance gaps around the globe, catalyze innovative projects, share best practices, and foster greater collaboration.
Our vital and ambitious vision is to democratize disease surveillance using these three approaches.
DETECT: Applying technology to find outbreaks faster by co-creating open source tools, data analytics, and collaborative information-sharing systems
VERIFY: Enabling a network of health professionals to verify rumors or the earliest signs of a potential outbreak through a crowdsourced web-based platform
CONNECT: Working across borders to connect multi-sectoral practitioners and build trust-based networks for learning, sharing best practices, and systemic change across geographic borders
Ending Pandemics provides scientific, technical and financial support to find, verify, and contain outbreaks faster in emerging disease hotspots. We apply technology, build local capacity, and work across borders – both geographical and sectoral.
Because sixty percent of infectious diseases found in humans are contracted from animals, the only way to ensure a pandemic threat is averted is to take a One Health approach.
Ending Pandemics captures early signals of diseases in animals and humans to prevent and/or limit it from spreading. Our efforts to monitor and prevent a pandemic threat require working with physicians, veterinarians, government officials, environmentalists, and others.
Our holistic user-centered approach generates solutions that are locally created, accessible to all, and sustainable with local resources after a catalytic investment.
This work is emboldened by evidence that the earlier we can detect a disease and the faster we can notify communities about it, the fewer lives and livelihoods will be lost.
Impact: How We Measure Progress
Our progress in improving disease surveillance in animals and humans should lead to:
- An increase in the number of outbreaks reported
- A decrease in the time to detect any outbreak
- A decrease in the time to verify any outbreak
We have conducted pilot studies in 28 countries to assess the feasibility of collecting these metrics.